全部文献期刊会议图书|学者科研项目
中外文文献  中文文献  外文文献
作者:... Sven Wind , Guilhem Bousquet , Jean-Louis Misset
来源:[J].SpringerPlus, 2016, Vol.5 (1), pp.1-12
摘要:Abstract(#br)Phase II, open-label study assessing the efficacy and safety of the ErbB family blocker afatinib combined with letrozole in estrogen receptor-positive metastatic breast cancer (MBC) patients who had progressed on letrozole monotherapy. Adult females ( N = 28) receive...
作者:Jean-Louis Misset
来源:[J].Seminars in Oncology(IF 4.327), 2002, Vol.29 (1), pp.36-39
摘要:Abstract(#br)Pemetrexed (Alimta, LY231514) is a novel, multitargeted antifolate that is broadly active in a wide variety of solid tumors, including genitourinary malignancies. This agent has also shown clinically relevant activity in combination with other agents, including gemci...
作者:Etienne G.C. Brain , Jean-Louis Misset , Jacques Rouëssé
来源:[J].Cancer Treatment Reviews(IF 6.024), 1999, Vol.25 (4), pp.187-197
摘要:Abstract(#br)Scientific rationale for primary treatment of breast cancer relies on experimental data showing that the incidence and growth of disease correlate with the primary tumour mass and tumoral anglogenesis. Although the strategy may be applied to both chemotherapy an...
作者:... Marie-Elisabeth Toubert , Pascal Merlet , Jean-Louis Misset
来源:[J].European Journal of Radiology(IF 2.512), 2014, Vol.83 (10), pp.1925-1933
摘要:Abstract(#br)Purpose(#br)Male breast cancer (BC) is a rare disease, with patterns different from those found in women. Most tumors are detected at more advanced stages than in women. The aim of this study was to analyze the performance of [18F]fluorodeoxyglucose positron emi...
作者:... Hervé Bismut , Jean-Louis Misset , Michel Marty
来源:[J].Critical Reviews in Oncology and Hematology(IF 4.637), 2005, Vol.54 (3), pp.165-170
摘要:Abstract(#br)In terms of systemic chemotherapy, the oncologist is often faced with the difficulty to discriminate between several options, at least according to evidence-based medicine. The aim of the present report was to assess to what extent the efficacy-related parameters req...
作者:Jean-Louis Misset , Cécile de Labareyre ...
来源:[J].Critical Reviews in Oncology and Hematology(IF 4.637), 2007, Vol.64 (2), pp.106-114
摘要:Abstract(#br)Over the last decades, the development of new drugs has allowed cancer patients to experience several lines of chemotherapy, the objective of which is a long term stabilization of the tumour. The objectives of this work was to delineate a composite index of rela...
作者:... Jean-Emmanuel Filmont , Farid Sarandi , Jean-Louis Misset
来源:[J].International Journal of Radiation Oncology, Biology, Physics(IF 4.524), 2008, Vol.71 (3), pp.695-704
摘要:Purpose(#br)To investigate the potential effect of using 18 F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) in the initial assessment of patients with clinical Stage II or III breast cancer.(#br)Methods and Materials(#br)During 14 consecutive months...
作者:Jean-Louis Misset
来源:[J].Bulletin du Cancer(IF 0.605), 2013, Vol.100 (5), pp.403-406
作者:Jean-Louis Misset , Jean-Marc Nabholtz ...
来源:[J].Bulletin du Cancer(IF 0.605), 2011, Vol.98 (7), pp.807-825
摘要:Abstract(#br)Apart from therapeutic advances related to new treatments, our practices in the management of early breast cancer have been modified by to key organizational settings (1) mass screening, substantially altering the presentation and epidemiology of breast cancer and (2...

我们正在为您处理中,这可能需要一些时间,请稍等。

资源合作:cnki.scholar@cnki.net, +86-10-82896619   意见反馈:scholar@cnki.net

×